Advanced search
Publication Cover
Pharmacogenomics Volume 20, 2019 - Issue 8
Submit an article Journal homepage
1,680
Views
0
CrossRef citations to date
0
Altmetric
Editorial

The Importance and Challenges of Developing a Pharmacogenetics Test for Hypertension

Eric M Snyder1 Geneticure, Inc., Rochester, MN55902, USA
,
Eli F Kelley2 School of Kinesiology, University of Minnesota, Minneapolis, MN55455, USA
,
Ryan Sprissler1 Geneticure, Inc., Rochester, MN55902, USA;3 University of Arizona Genomics Core, Tucson, Arizona, AZ85721USA
&
Thomas P Olson1 Geneticure, Inc., Rochester, MN55902, USA;4 Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN55905, USACorrespondence[email protected]
Pages 563-566 | Received 15 Apr 2019, Accepted 26 Apr 2019, Published online: 28 May 2019

References

  • Bray MS , KrushkalJ , LiLet al. Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation101(25), 2877–82 (2000).
  • Chapman AB , SchwartzGL , BoerwinkleE , TurnerST. Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension. Kidney Int.61(3), 1047–55 (2002).
  • Hiltunen TP , DonnerKM , SarinAPet al. Pharmacogenomics of hypertension: a genome-wide, placebo-controlled cross-over study, using four classes of antihypertensive drugs. J. Am. Heart Assoc.4(1), e001521 (2015).
  • Hottenga JJ , BoomsmaDI , KupperNet al. Heritability and stability of resting blood pressure. Twin Res. Hum. Genet.8(5), 499–508 (2005).
  • Snieder H et al. Heritability of central systolic pressure augmentation: a twin study. Hypertension35(2), 574–579 (2000).
  • Turnbull F , NealB , AlgertCet al. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch. Intern. Med.165(12), 1410–1419 (2005).
  • Gupta P , PatelP , ŠtrauchBet al. Risk factors for nonadherence to antihypertensive treatment. Hypertension69(6), 1113–1120 (2017).
  • Lefebvre J , PoirierL , PoirierP , TurgeonJ , LacourciereY. The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertension. Br. J. Clin. Pharmacol.63(5), 575–582 (2007).
  • Zineh I , BeitelsheesAL , GaedigkAet al. Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension. Clin. Pharmacol. Ther.76(6), 536–544 (2004).
  • Pletcher MJ , McCullochCE. The challenges of generating evidence to support precision medicine. JAMA Intern. Med.177(4), 561–562 (2017).
  • Phelps PK , KelleyEF , WallaDMet al. Relationship between a weighted multi-gene algorithm and blood pressure control in hypertension. J. Clin. Med.8(3), (2019).
  • Sanada H , JonesJE , JosePA. Genetics of salt-sensitive hypertension. Curr. Hypertens. Rep.13(1), 55–66 (2011).
  • van Wieren-de Wijer DB , Maitland-vander Zee AH , de BoerAet al. Interaction between the Gly460Trp alpha-adducin gene variant and diuretics on the risk of myocardial infarction. J. Hypertens.27(1), 61–68 (2009).
  • Psaty BM , SmithNL , HeckbertSRet al. Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension. JAMA287(13), 1680–1689 (2002).
  • Johnson JA , ZinehI , PuckettBJ , McGorraySP , YarandiHN , PaulyDF. Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol. Clin. Pharmacol. Ther.74(1), 44–52 (2003).
  • Magvanjav O , McDonoughCW , GongYet al. Pharmacogenetic associations of beta1-adrenergic receptor polymorphisms with cardiovascular outcomes in the SPS3 trial (secondary prevention of small subcortical strokes). Stroke48(5), 1337–1343 (2017).
  • Turner ST , SchwartzGL , BoerwinkleE. Personalized medicine for high blood pressure. Hypertension50(1), 1–5 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.